Skip to content
Clinical Trials – home

FILGRASTIM: A Comprehensive Guide for Patients

19 / 33
trials open to patients / all trials
20+
Countries

In short

Filgrastim, a recombinant granulocyte colony-stimulating factor (G-CSF), is being extensively studied in clinical trials for its potential to improve outcomes in cancer patients undergoing chemotherapy. This article explores how Filgrastim is being used to manage neutropenia, enhance stem cell mobilization, and potentially promote collateral growth in coronary artery disease.

At a glance

Primary Use
Prevention and treatment of chemotherapy-induced neutropenia in cancer patients
Administration
Subcutaneous injection, typically daily for 5-10 days following chemotherapy
Key Benefits
Reduces risk of infection, allows maintenance of chemotherapy dose intensity
Common Side Effects
Bone pain, fatigue, mild flu-like symptoms
Emerging Applications
Stem cell mobilization, potential use in coronary artery disease, fertility treatments
Monitoring
Regular blood tests to check neutrophil counts and other blood cell levels
Cost Considerations
Significant cost per injection, potential for substantial savings with optimized dosing schedules

What is Filgrastim?

Filgrastim is a medication that belongs to a class of drugs called granulocyte colony-stimulating factors (G-CSF). It is also known by several other names, including:

  • Neupogen
  • GCSF
  • rG-CSF (recombinant Granulocyte Colony Stimulating Factor)
  • Tbo-filgrastim
  • ZARZIO

These names may be used interchangeably in medical settings, but they all refer to the same medication or very similar versions of it.

How Filgrastim Works

Filgrastim works by stimulating the bone marrow to produce more white blood cells, specifically a type called neutrophils. Neutrophils are crucial for fighting infections in the body. When a person has a low neutrophil count (a condition called neutropenia), they are at higher risk for infections.

The medication mimics a natural protein in your body that tells the bone marrow to make more of these important cells. By increasing the number of neutrophils, Filgrastim helps to strengthen the body's immune system and its ability to fight off infections.

Medical Uses of Filgrastim

Filgrastim is used in several medical situations:

  1. Cancer Treatment: It's commonly used in patients undergoing chemotherapy. Chemotherapy can lower white blood cell counts, and Filgrastim helps to boost them back up, reducing the risk of infections.
  2. Bone Marrow Transplants: Filgrastim can help stimulate the growth of new white blood cells after a bone marrow transplant.
  3. Stem Cell Collection: It's used to mobilize stem cells from the bone marrow into the bloodstream, where they can be collected for transplantation procedures.
  4. Severe Chronic Neutropenia: In patients with persistently low neutrophil counts due to various conditions, Filgrastim can help maintain a healthier white blood cell level.
  5. HIV/AIDS: It may be used in HIV patients to help maintain neutrophil counts and reduce the risk of bacterial infections.

How Filgrastim is Administered

Filgrastim is typically given as an injection under the skin (subcutaneously) or into a vein (intravenously). The dosage and duration of treatment can vary depending on the specific medical condition and individual patient factors.

For example:

  • In cancer patients receiving chemotherapy, it might be given daily for up to two weeks following each chemotherapy cycle.
  • For stem cell mobilization, it might be given for 4-5 days before the collection procedure.
  • In patients with chronic conditions, it may be given on a long-term basis.

The exact schedule will be determined by your healthcare provider based on your specific needs and response to the medication.

Potential Side Effects

Like all medications, Filgrastim can cause side effects. Common side effects may include:

  • Bone pain
  • Headache
  • Nausea
  • Skin rash
  • Fatigue
  • Fever

Most side effects are mild and manageable. However, in rare cases, more serious side effects can occur. It's important to report any unusual symptoms to your healthcare provider.

Ongoing Research and Future Potential

Researchers continue to explore new uses for Filgrastim. Some areas of ongoing research include:

  • Cardiovascular Disease: Studies are investigating whether Filgrastim can help promote the growth of new blood vessels in patients with coronary artery disease.
  • Fertility Treatment: Some research is looking at whether Filgrastim could help improve outcomes in certain fertility treatments.
  • Premature Ovarian Insufficiency: There's ongoing research to see if Filgrastim could help improve ovarian function in women with this condition.
  • Severe Skin Reactions: Studies are investigating the potential use of Filgrastim in treating severe drug-induced skin reactions.

These areas of research are still in early stages, and more studies are needed to determine if Filgrastim will be effective for these conditions.

Questions people often ask

Conditions where Filgrastim is being studied

Each condition opens its own overview and trial list

Trials with Filgrastim

Recruiting trials first

See all 33 →
Quick filters
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.